Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome
- PMID: 16684376
- PMCID: PMC1526632
- DOI: 10.1186/ar1950
Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome
Abstract
Fibromyalgia (FM) pain is frequent in the general population but its pathogenesis is only poorly understood. Many recent studies have emphasized the role of central nervous system pain processing abnormalities in FM, including central sensitization and inadequate pain inhibition. However, increasing evidence points towards peripheral tissues as relevant contributors of painful impulse input that might either initiate or maintain central sensitization, or both. It is well known that persistent or intense nociception can lead to neuroplastic changes in the spinal cord and brain, resulting in central sensitization and pain. This mechanism represents a hallmark of FM and many other chronic pain syndromes, including irritable bowel syndrome, temporomandibular disorder, migraine, and low back pain. Importantly, after central sensitization has been established only minimal nociceptive input is required for the maintenance of the chronic pain state. Additional factors, including pain related negative affect and poor sleep have been shown to significantly contribute to clinical FM pain. Better understanding of these mechanisms and their relationship to central sensitization and clinical pain will provide new approaches for the prevention and treatment of FM and other chronic pain syndromes.
Figures
Comment in
-
Fibromyalgia and sleep-disordered breathing: the missing link.Arthritis Res Ther. 2008;10(6):408; author reply 409. doi: 10.1186/ar2538. Epub 2008 Nov 25. Arthritis Res Ther. 2008. PMID: 19090966 Free PMC article. No abstract available.
References
-
- Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–172. - PubMed
-
- Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, Lopez Y, MacKillip F. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37:1593–1601. - PubMed
-
- Bradley LA, Alarcon GS, Sotolongo A, Weigent DA, Alberts KR, Blalock JE, Kersh BC, Domino ML, De Waal D. Cerebrospinal fluid (CSF) levels of substance P (SP) are abnormal in patients with fibromyalgia (FM) regardless of traumatic or insidious pain onset. Arthritis Rheum. 1998;41:S256. doi: 10.1002/1529-0131(199802)41:2<256::AID-ART9>3.0.CO;2-E. - DOI
-
- Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand J Rheumatol. 2000;29:8–12. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
